Evidence map›Paper›PMID 38713702›Full record

ArticleAlzheimer's & dementia : the journal of the Alzheimer's Association2024

Correlation analysis of peripheral platelet markers and disease phenotypes in Alzheimer's disease.

Jiajia Fu, Xiaohui Lai, Chongwei Zhang, Qianqian Wei, Xueping Chen, Huifang Shang

Abstract read
In one paragraph

Article in Alzheimer's & dementia : the journal of the Alzheimer's Association, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Tuft Cells in the Gut Limit Cognitive Disorders by Regulating Gut Homeostasis.Cellular and molecular gastroenterology and hepatology · 2026
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Correlation analysis of peripheral platelet markers and disease phenotypes in Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Jiajia FuDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xiaohui LaiDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Chongwei ZhangDepartment of Experimental Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Qianqian WeiDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.
Xueping ChenDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.ORCID 0000-0003-4290-7404
Huifang ShangDepartment of Neurology, West China Hospital, Sichuan University, Chengdu, Sichuan, China.

Funding

Cadres Health Care Project in Sichuan Province 2023-111Clinical Research Incubation Project of West China Hospital of Sichuan University 20HXFH035National Key Research and Development Program of China 2021YFC2501200Science and Technology Bureau Fund of Sichuan Province of China 2023YFQ0098Sichuan Science and Technology Program 2022ZDZX0023
6 · The paper itself

Abstract

introductionPlatelets serve as the primary peripheral reservoir of amyloid beta (Aβ). However, there is limited research on platelet markers in routine blood examinations, particularly with regard to the large platelet ratio (P-LCR) in Alzheimer's disease (AD).

methodsThis study included 512 AD patients and 205 healthy controls (HCs). Platelet markers and apolipoprotein E (APOE) 4 status were assessed in all participants.

resultsThe study revealed that P-LCR was significantly elevated in AD patients compared to HCs. In AD patients carrying APOE4, P-LCR significantly negatively correlated with Montreal Cognitive Assessment scores. There was an observed increasing trend in the rate of change in P-LCR with disease progression. Binary logistic regression analysis indicated that P-LCR may constitute a risk factor for AD, after adjusting for age, sex, APOE4, and body mass index. DISCUSSION: P-LCR is associated with disease severity in AD patients carrying APOE4. P-LCR may be a promising marker to reflect platelet activity in AD patients. HIGHLIGHTS: P-LCR significantly negatively correlated with MoCA scores in AD patients with APOE4. The rate of change in P-LCR showed an increasing trend with disease progression. P-LCR may be a risk factor for AD.

Indexed as

Alzheimer DiseaseApolipoprotein E4BiomarkersBlood PlateletsAgedDisease ProgressionFemaleHumansMaleMiddle AgedPhenotypePlatelet CountApolipoprotein E4BiomarkersAlzheimer's diseaseAPOE geneplatelet markers

Identifiers

PMID38713702
PMCPMC11180931

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.